19Oct
16Oct
Salesforce-backed Bay Area entrepreneur strikes big deal to ‘crush’ student loan debt
Laurel Taylor, founder and CEO of FutureFuel.io, knows firsthand the opportunities and struggles that come with taking on large student loans to pay for college, so she created FutureFuel.io, a digital platform that helps borrowers manage their student loans. Borrowers using FutureFuel.io to enroll in federal repayment plans cut their monthly payments on average by $326, according to the company. FutureFuel.io also helps users generate funds to pay back student loans through services that allow companies to offer student-loan repayment...
14Oct
Takeda bets up to $900M on Immusoft’s cell therapies for neurometabolic disorders
Immusoft has inked its first Big Pharma collaboration in a deal with biotech's best friend Takeda worth up to $900 million that sees the pair work on cell therapies in rare inherited disorders. The pact will focus on neurometabolic disorders, Immusoft said Wednesday. The deal comes as the Seattle-based biotech nears the clinic for the first time in its decadelong journey working on sustained protein delivery for rare diseases. Read more >>
13Oct
FutureFuel.io Reaches New Student Debt Borrowers with Fiserv Partnership
FutureFuel.io, a technology firm that helps America’s 47.9 million borrowers crush their student loan debt, announced today a new partnership with Fiserv. This partnership will enable banks and credit unions to bring the FutureFuel.io student loan repayment platform to consumers, providing personalized, dynamic student debt management to millions of borrowers nationwide. Read more >>
13Oct
The 17 Best Dating Sites and Apps – It’s time to meet your match
There are a ton of dating apps and websites that will help you get started—Gone is the concept of swiping right or left based on looks; instead, S'more users first establish connections based on mutual interests. Each day you'll receive recommended profiles based on your previous activity on the app (the algorithm takes into account the kind of people you swipe 'yes' to the most), but the matches' photos are blurred and only become visible when you engage with the...
08Oct
Silo Pharma achieves milestone – Partner Zylo Therapeutics Receive DEA Approval to Advance Silos time released Ketamine technology
Silo Pharma, Inc. a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, today announced that their joint venture partner Zylo Therapeutics received approval from the DEA to advance the development of their Z-pod technology in combination with Ketamine. Read more >>
07Oct
American pioneers bring vision of a more inclusive, innovative and sustainable wine industry to wine2wine Business Forum
Marian Leitner-Waldman, Founder and CEO of Archer Roose, one of America’s leading canned wine producers, and Alicia Towns Franken, VP Wine Portfolio at Archer Roose, will deliver two sessions on their vision for a more inclusive and sustainable wine industry, in person at the wine2wine Business Forum in Verona on 18/19 October 2021. Franken will focus on the democratization of wine, and Leitner-Waldman will discuss on-premise wine program. Read more >>
06Oct
eSight Announces New Partnership with Merlin Entertainments to Change Lives Around The World
Leading vision-enhancement platform, eSight, announces a new partnership with Merlin Entertainments, one of the largest attractions operators in the world. Together, the companies will provide multiple life-changing experiences for individuals with vision impairment. In addition, eSight and Merlin will work together to create more inclusive initiatives for future guests with low vision or legal blindness. eSight and Merlin Entertainments are working together to create once-in-a-lifetime experiences at Merlin Entertainments' LEGOLAND® Parks, LEGOLAND® Discovery Center and SEA LIFE locations. Read more...
05Oct
Brain injury therapy advancing toward human studies
Research that began at The University of Texas Health Science Center at San Antonio 15 years ago is nearing a significant milestone: human testing of an intravenous (IV) drug to treat brain injuries such as concussion and stroke. The implications are enormous. A therapy for soldiers on the battlefield, car crash victims, concussed football players and people who suffer strokes could ease the pain and suffering of thousands worldwide daily and prevent debilitating long-term effects of traumatic brain injury. Astrocyte Pharmaceuticals is...
05Oct